Investing
Other Investing
Vertex Pharmaceuticals Other Investing increased by 2087.5% to $15.90M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 48.5%, from $30.90M to $15.90M. Over 3 years (FY 2022 to FY 2025), Other Investing shows a downward trend with a -19.8% CAGR.
Analysis
StatementCash Flow Statement
SectionInvesting
CategoryOther
SignalContext dependent
VolatilityStable
First reportedQ4 2013
Last reportedQ4 2025
How to read this metric
Generally neutral, but large fluctuations may indicate non-recurring events or specific financial adjustments that warrant further investigation.
Detailed definition
This metric aggregates miscellaneous cash inflows and outflows related to investing activities that do not fit into stan...
Peer comparison
Usually a small component of total investing cash flow; peers report similar miscellaneous items based on specific accounting treatments.
Metric ID:
cf_other_investingHistorical Data
16 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $11.95M | $11.95M | $11.95M | $11.95M | $7.75M | $7.75M | $7.75M | $7.75M | $0.00 | $15.00M | $8.10M | $30.90M | $5.30M | $4.30M | -$800.00K | $15.90M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | -35.1% | +0.0% | +0.0% | +0.0% | -100.0% | — | -46.0% | +281.5% | -82.8% | -18.9% | -118.6% | >999% |
| YoY Change | — | — | — | — | -35.1% | -35.1% | -35.1% | -35.1% | -100.0% | +93.5% | +4.5% | +298.7% | — | -71.3% | -109.9% | -48.5% |
Range-$800.00K – $30.90M
CAGR+7.9%
Avg YoY Growth-6.7%
Median YoY Growth-35.1%
Other Investing at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's other investing?
- Vertex Pharmaceuticals (VRTX) reported other investing of $15.90M in Q4 2025.
- How has Vertex Pharmaceuticals's other investing changed year-over-year?
- Vertex Pharmaceuticals's other investing decreased by 48.5% year-over-year, from $30.90M to $15.90M.
- What is the long-term trend for Vertex Pharmaceuticals's other investing?
- Over 3 years (2022 to 2025), Vertex Pharmaceuticals's other investing has grown at a -19.8% compound annual growth rate (CAGR), from $47.80M to $24.70M.
- What does other investing mean?
- Miscellaneous cash flows related to investing that are not categorized elsewhere.